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Summary
Juvenile hemochromatosis (JH) is an autosomal recessive
disorder that leads to severe iron loading in the 2d to
3d decade of life. Affected members in families with JH
do not show linkage to chromosome 6p and do not have
mutations in the HFE gene that lead to the common
hereditary hemochromatosis. In this study we performed
a genomewide search to map the JH locus in nine fam-
ilies: six consanguineous and three withmultiple affected
patients. This strategy allowed us to identify the JH locus
on the long arm of chromosome 1. A maximum LOD
score of 5.75 at a recombination fraction of 0 was de-
tected with marker D1S498, and a LOD score of 5.16
at a recombination fraction of 0 was detected for marker
D1S2344. Homozygosity mapping in consanguineous
families defined the limits of the candidate region in an
∼4-cM interval between markers D1S442 and D1S2347.
Analysis of genes mapped in this interval excluded ob-
vious candidates. The JH locus does not correspond to
the chromosomal localization of any known gene in-
volved in iron metabolism. These findings provide a
means to recognize, at an early age, patients in affected
families. They also provide a starting point for the iden-
tification of the affected gene by positional cloning.
Introduction
Juvenile hemochromatosis, or hemochromatosis type 2
(JH; MIM 602390), is an inborn error of iron metab-
olism that leads to severe iron loading and organ failure
at age !30 years (Camaschella 1998). JH is a rare dis-
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order, characterized by an autosomal recessive inheri-
tance. The patterns of iron distribution and tissue injury
are similar to those in hemochromatosis type 1, or HFE-
related hereditary hemochromatosis (HH), a common
genetic disorder with clinical expression in middle life
(Powell et al. 1994; Camaschella and Piperno 1997). In
contrast with HH, which predominantly affects males,
in JH both sexes are equally affected. The clinical com-
plications of iron overload—liver cirrhosis, cardiac dis-
ease, endocrine failure, diabetes, arthropathy, and skin
pigmentation—are similar to those of HH, but hypo-
gonadism and cardiopathy are the most common symp-
toms at presentation. Heart failure and/or major ar-
rhythmias are usually the cause of death in the absence
of treatment. Early detection of the disorder is impor-
tant, because iron depletion by phlebotomy can prevent
organ damage and all the disease manifestations (Ca-
maschella 1998). Recent studies have shown that pa-
tients with JH (1) do not have mutations in the HFE
gene that lead to HH (Feder et al. 1996) and (2) do not
show linkage to 6p (Camaschella et al. 1997). The bi-
ochemical defect of the disorder is unknown; however,
iron absorption is greater in JH than in HH (Cazzola et
al. 1983), and the estimated rate of iron accumulation,
based on phlebotomy requirements for maintenance of
normal iron balance, is significantly higher in patients
with JH than in patients with HH (Cazzola et al. 1998).
The study of JH may contribute to our understanding
of the molecular mechanisms regulating iron absorption.
Evidence from in vitro studies (Feder et al. 1998) and
studies of placental cells (Pakkila et al. 1997) has shown
that the HFE protein may interact with the transferrin
receptor, reducing its affinity for transferrin (Lebron et
al. 1998). However, whether and how this interaction
affects the regulatory cellular iron pool remains uncer-
tain, and the molecular mechanisms that underlie the
increased iron absorption in HH, following the lack of
the mutant HFE protein on the cell surface, remain un-
clear. The severity and the early expression of JH suggest
a derangement of a gene product that is crucial in the
regulation of iron uptake.
The disease, although quite rare, has been reported in
different ethnic groups (Lamon et al. 1978; Cazzola et
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Figure 1 Haplotype analysis of chromosome 1q markers of the JH kindreds. Marker order is according to the available maps. Homozygosity
regions are boxed with a thick line in families 1–6. Haplotypes associated with the disease are boxed with a thin line in families 7–9.
Recombinations are indicated by an asterisk (*). The shaded areas correspond to segments of haplotypes shared by normal and affected subjects
in family 8. Alleles are coded, with “1” indicating the shorter-size allele.
al. 1983; Haddy et al. 1988; Kelly et al. 1998). A few
cases with a high level of consanguinity have been de-
scribed in Italy (Camaschella et al. 1997; Cazzola et al.
1998) that confirm the rarity of the disorder (Camas-
chella et al. 1997).
We conducted a full human-genome search in nine
families with JH; three families were multiplex and six
were consanguineous. By using homozygosity mapping
(Lander and Boistein 1987) and linkage analysis, we
found genetic linkage between the disease and several
markers in an ∼4-cM region of chromosome 1q.
Subjects and Methods
JH Families
Nine families with JH were included in the study. The
pedigrees are shown in figure 1. Eight kindreds (families
1–8) were Italian. Families 1, 2, and 5–7 (Camaschella
et al. 1997), family 3 (Cazzola et al. 1998), and family
8 (Cazzola et al. 1983) have been reported elsewhere.
Family 9 is of British origin and corresponds to pedigree
C, reported by Kelly et al. (1998). The parents in families
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1–6 were first cousins, and three families (7–9) were
multiplex.
Criteria for the diagnosis of JH were based on the age
at presentation of the disorder and the clinical evidence
of severe iron overload in the absence of mutations in
the HFE gene. In all patients, clinical symptoms of hy-
pogonadism were present at age !30 years. Cardiac dis-
ease, as defined by heart failure and/or left-ventricular
dilatation with low ejection fraction at echocardio-
graphy or arrythmias requiring medical treatment (Pi-
perno et al. 1996), was present in at least one patient
in each family except family 9. The degree of iron over-
load was determined on the basis of liver biopsy, liver
iron concentration, and/or quantitation of iron removed
by phlebotomies, as described elsewhere (Piperno et al.
1996). Detailed clinical descriptions of the cases are
available (Cazzola et al. 1983, 1998; Camaschella et al.
1997; Kelly et al. 1998). Patient II-2 of family 4 was
not reported elsewhere but presents clinical features that
fit the JH general criteria described above. The obligate-
heterozygous parents examined did not display any clin-
ical symptoms.
Molecular Studies
EDTA blood samples were collected for genetic studies
after informed consent was obtained in accordance with
the guidelines of the local institutions. DNA was ob-
tained from lymphoblastoid cell lines in patients be-
longing to families 1, 5, and 6 and from peripheral blood
buffy coats in the other patients and healthy relatives.
DNA was prepared by standard phenol-chloroform ex-
traction (Sambrook et al. 1989). In total, we had access
to DNA samples from 39 subjects (12 patients and 27
healthy relatives).
For the genomewide search (GWS), the ABI PRISM
Linkage Mapping Set (Perkin-Elmer) was used. This set
is characterized by 1375 markers that define a 10-
cM–resolution human index map (Gyapay et al. 1994).
PCR with fluorescently labeled primers was done under
the conditions suggested by the supplier. An aliquot of
the PCR mixture was reacted in an ABI PRISM 373 or
377 DNA sequencer, and the results were processed by
GENESCAN software. Allele assignment was done with
the GENOTYPERTM (Perkin-Elmer) software. To satu-
rate the potentially homozygous regions, especially the
chromosome 1 region, additional pairs of fluorescently
labeled primers were specifically synthesized for markers
proximal and distal to panel markers (Dib et al. 1996).
Primer sequences and PCR conditions were obtained
from the Whitehead Institute Database. All living indi-
viduals of each family were genotyped and thus con-
tributed to linkage calculation. Extended haplotypes
were constructed by analysis of the segregation of
marker alleles within the families.
Linkage Analysis
Statistical analysis was performed on the basis of an
assumption of autosomal recessive disease with complete
penetrance. The disease-gene frequency was set to .0001,
and all marker alleles were considered to be equally fre-
quent. Two-point linkage analysis was performed by
means of the MLINK program, version 5.1, from the
LINKAGE computer package (Ott 1992). Loops of con-
sanguinity were accommodated, as suggested by Ott
(1992). Values for maximum LOD score (Zmax) were
calculated with the ILINK program from the same com-
puter package. The ∼95% confidence limits for the max-
imum recombination fraction (vmax) at Zmax were cal-
culated by the 1-LOD-down method (Ott 1992). Alleles
were coded within each family, without loss of inform-
ativeness, to reduce computing time. The HOMOG pro-
gram was used to test for nonallelic heterogeneity by
means of pairwise LOD scores between D1S498 and the
disease locus.
Results
Mapping the JH Locus
The GWS was performed on the DNA of the originally
described six patients from five unrelated families (Ca-
maschella et al. 1997). After analyzing data from all
markers included in the panel, we found evidence for
linkage, by homozygosity mapping of the following
chromosomal regions: 18q (D18S64), 1q(D1S498), 7p
(D7S493), 12q (D12S324), and 11p (D11S935). Several
additional markers from each region were then typed in
all individuals of the five families used for the GWS and
in an additional four families. This analysis allowed us
to exclude all the candidate areas except the pericen-
tromeric region of chromosome 1.
According to available maps (Whitehead Institute
Database and Genetic Location Database), the order
of the additional markers in this region is D1S2669-
GATA12A07-D1S2696-cen-D1S442-D1S2344-
D1S498-D1S2347-D1S2343-D1S2345-D1S1664-tel.
The markers map to the same Whitehead Institute
single-linked YAC contig (WC1.16). The marker po-
sition was verified by PCR assays on a YAC contig
of the region enriched for all the markers available
(data not shown). The relative positions of markers
D1S2345 and D1S2343 could not be resolved.
Pairwise LOD scores for the markers studied are
shown in table 1. The highest LOD score was obtained
with D1S498 (Zmax  5.75 at v  .00), but no recom-
binants were detected with D1S2344 (Zmax  5.16 at v
 .00) and D1S442 (Z .30 at v .00). Positive results
were also obtained with the remaining markers, at v 1
. The HOMOG program identified no evidence in sup-0
port of genetic heterogeneity (x2  26.49; a  1).
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Table 1
Pairwise LOD Scores between JH and Chromosome 1 Markers
MARKERS
Z AT v 
Zmax (vmax).00 .01 .05 .10 .20 .30 .40
D1S2669 4.11 1.33 2.16 2.08 1.43 .75 .24 2.18 (.060)
GATA12A07 3.26 1.88 2.63 2.44 1.61 .80 .24 2.63 (.054)
D1S2696 8.64 .15 1.36 1.56 1.16 .59 .16 1.57 (.094)
D1S442 .30 2.90 3.03 2.63 1.66 .81 .24 3.09 (.030)
D1S2344 5.16 5.01 4.41 3.67 2.32 1.22 .42 5.16 (.000)
D1S498 5.75 5.56 4.84 3.97 2.39 1.16 .37 5.75 (.000)
D1S2347 .26 2.53 2.72 2.38 1.49 .73 .23 2.76 (.034)
D1S2343 .40 2.19 2.41 2.13 1.39 .74 .27 2.43 (.036)
D1S2345  1.87 2.67 2.53 1.72 .91 .31 2.68 (.058)
D1S1664  .72 .84 1.11 .86 .46 .15 1.11 (.106)
Haplotype Analysis and Recombination Events
Results of the analysis of chromosome 1 markers are
shown in figure 1. The results of haplotype analysis sup-
port the marker order shown in the figure. Affected sib-
lings in multiplex families (families 7–9) have inherited
the same haplotype combination, whereas healthy sub-
jects do not share the same haplotypes with their affected
siblings. A recombination event was detected in case II-
4 of family 8, occurring between D1S2347 and D1S2345
(fig. 1), which helps in definition of the telomeric limit
of the JH critical region.
As expected, regions of homozygosity of variable ex-
tent are observed in all affected individuals in kindreds
with first-cousin matings (families 1–6). Consistent ho-
mozygosity regions in all patients include markers
D1S2344 and D1S498. A heterozygous genotype for
D1S442 is found in patient II-1 of family 6, thus defining
the centromeric limit. In addition, case II-2 in family 4
is heterozygous at D1S2347 marker, which defines the
telomeric limit. The region spanning D1S442–D1S2347
is ∼4 cM on chromosome 1q.
Candidate Gene Analysis
The CD1D gene was evaluated as a potential candi-
date gene in the defined interval. To assess its candidacy,
the polymorphic tetranucleotide CHLC.GATA3B11 was
analyzed. This marker maps to the same well-charac-
terized YAC 748F9 as does CD1D. The results obtained
show that three of six patients expected to be homo-
zygous (II-1 in family 2, II-2 in family 4, and II-1 in
family 6) are heterozygous at this locus (data not
shown). In addition, both CHLC.GATA3B11 and
D1S3312, a sequence-tagged site (STS) corresponding to
the CD1D fifth exon, do not map to the YAC contig
covering the defined critical region (data not shown).
Discussion
This study provides evidence that the JH locus maps
to chromosome 1q, in an ∼4-cM interval defined by
markers D1S442 and D1S2347. Given the small number
of families evaluated, this study emphasizes the power
that homozygosity mapping, combined with the avail-
ability of a dense microsatellite map, has in the locali-
zation of genes that cause rare recessive diseases.
In the defined interval on chromosome 1q, several
known genes, as well as multiple unidentified transcripts,
are mapped. Known genes include genes with immu-
nological functions, such as T-complex g-subunit, a
high-affinity g-Fc receptor, and CD2. The CD1 cluster,
which consists of five atypical HLA class I genes (CD1A,
CD1B, CD1C, CD1D, and CD1E), maps in the prox-
imity of the critical region, to the same single-linked YAC
contig WC1.16. This is an interesting fact, considering
that the HFE gene responsible for HH is an atypical
HLA class I gene (Feder et al. 1996). CD1A, CD1B, and
CD1 are involved in glycolipid-antigen presentation
(Porcelli et al. 1998). CD1D is highly conserved in ev-
olution, has an unusual structure with a narrow binding
grove, similar to other class I genes such as FcnR and
HFE (Wilson and Bjorkman 1998), and is highly ex-
pressed in intestinal epithelial cells (Kasai et al. 1997).
The CD1D structural features, its pattern of expression,
and its map position prompted us to evaluate this gene
as a potential candidate for JH. However, the candidacy
of CD1D was excluded on the basis of both homozy-
gosity and physical mapping. Preliminary results show
that patients expected to be homozygous are instead
heterozygous at a polymorphic marker closely associated
with this locus. In addition, both the CD1D-associated
marker and the STS corresponding to the CD1D fifth
exon map outside the minimal critical region. No other
genes in the defined interval are obvious candidates for
JH.
Our future effort will be to enrich the identified in-
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terval of polymorphic markers. No common haplotype
has been observed among patients with the studied
markers, likely because of the large extension of the re-
gion. If a shared haplotype is found inside the 4-cM
region, this will be used to restrict the candidate area.
The definition of the JH locus is a starting point for
the identification of the JH gene by positional cloning.
The immediate benefit of our results is to provide mark-
ers that allow the early detection of the disease in af-
fected families. The need for family counseling for he-
mochromatosis is usually based on HFE mutations or
HLA-A–haplotype segregation, which is of no value in
JH. Localization of the JH locus to chromosome 1q al-
lows analysis for linkage in other patients with atypical
forms of hemochromatosis without mutations in the
HFE gene (Carella et al. 1997) and/or without classical
juvenile expression (Camaschella et al., in press). From
a biological point of view, the results obtained in this
study indicate that the JH gene does not correspond to
any of the known genes involved in iron metabolism
whose chromosomal localization is defined. For this rea-
son, we expect that cloning the JH gene will identify a
new iron protein with a crucial role in iron metabolism.
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